자산 1
CLEO ONE
ENG KOR

New Products

Wizbiosolutions Inc. takes pride in being a pioneer of Point-of-Care Molecular Diagnostics. In response to the global pandemic, we offer technology innovations that enable accessible and reliable molecular diagnostic solutions.

Tuberculosis

EuDx™ MDR-TB Detection Kit
RNA Extraction

WizMag™ Bacterial RNA
HPV

WizDx™ CrystalMix HPV-HR
Instrument

CLEO™ AP48

Notice

September 18, 2025

CLEO™ Q16 Real-Time PCR system receives ANVISA registration in Brazil

Wizbiosolutions is pleased to announce that its CLEO™ Q16 real-time PCR system has been successfully registered as a Class II in vitro diagnostic (IVD) device with the Brazilian Health Regulatory Agency (ANVISA). The CLEO™ Q16 features f...

July 24, 2025

Obtained approval of MFDS for EuDx™ MDR-TB Detection Kit

EuDx™ MDR-TB Detection Kit has received approval from the Korean Ministry of Food and Drug Safety (MFDS). This kit is a real-time PCR assay that simultaneously tests for tuberculosis infection and two antibiotics, rifampicin (RIF) and isonazid...

News

February 27, 2024

Wizbiosolutions signs MOU for cooperation in the development of oral microorganism diagnostic products for oral health

Molecular diagnostic specialized company Wizbiosolution (CEO, Lee Hyun Young) announced the 3rd parties MOU with Industry Academic Cooperation group of SOOKMYUNG WOMEN’S University and Apple-Tree Medical Foundation at the DOCSMEDI Oralbiome C...

February 27, 2024

Ajou University-Wizbiosolutions Inc. MOU for Education and Research cooperation in the Bio-health field.

Wizbiosolutions and College of Advanced Biomedical Convergence from Ajou University signed up MOU to find a mutual research cooperation system in advanced biotech health fields, including digital bio and innovative medicine. (Feb. 2nd 2024) Wizbio...

Partners